Stifel Maintains Buy on Medtronic, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Buy rating on Medtronic (NYSE:MDT) and raises the price target from $90 to $92.
May 26, 2023 | 11:29 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel analyst Rick Wise maintains a Buy rating on Medtronic and raises the price target from $90 to $92.
The news of Stifel maintaining a Buy rating on Medtronic and raising the price target from $90 to $92 indicates a positive outlook for the company's stock. This could lead to an increase in investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100